The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group (Q45853602)
Jump to navigation
Jump to search
scientific article published in May 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group |
scientific article published in May 1990 |
Statements
1 reference
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group (English)
1 reference
Collier AC
1 reference
Fischl MA
1 reference
Richman DD
1 reference
Hansen N
1 reference
Carey JT
1 reference
Para MF
1 reference
Hardy WD
1 reference
Dolin R
1 reference
Powderly WG
1 reference
Allan JD
1 reference
1 May 1990
1 reference
1 reference
112
1 reference
10
1 reference
727-737
1 reference
Identifiers
1 reference
1 reference